HealthEquity, Inc. $HQY Stock Purchased by Retirement Systems of Alabama

Retirement Systems of Alabama raised its stake in HealthEquity, Inc. (NASDAQ:HQY) by 12.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 220,184 shares of the company’s stock after acquiring an additional 23,906 shares during the period. Retirement Systems of Alabama’s holdings in HealthEquity were worth $19,477,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently made changes to their positions in the company. Allspring Global Investments Holdings LLC raised its holdings in shares of HealthEquity by 8.1% in the third quarter. Allspring Global Investments Holdings LLC now owns 219,109 shares of the company’s stock valued at $19,582,000 after buying an additional 16,418 shares during the last quarter. Ethic Inc. boosted its stake in shares of HealthEquity by 21.9% during the third quarter. Ethic Inc. now owns 4,155 shares of the company’s stock worth $368,000 after buying an additional 746 shares during the period. Commonwealth Equity Services LLC boosted its stake in shares of HealthEquity by 92.9% during the third quarter. Commonwealth Equity Services LLC now owns 4,357 shares of the company’s stock worth $385,000 after buying an additional 2,098 shares during the period. Provenance Wealth Advisors LLC acquired a new stake in shares of HealthEquity during the third quarter worth about $187,000. Finally, Vise Technologies Inc. grew its holdings in shares of HealthEquity by 44.3% during the third quarter. Vise Technologies Inc. now owns 4,922 shares of the company’s stock worth $435,000 after buying an additional 1,510 shares during the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have commented on HQY shares. Raymond James Financial reaffirmed a “strong-buy” rating on shares of HealthEquity in a research note on Thursday, September 3rd. Deutsche Bank increased their price objective on HealthEquity from $135.00 to $142.00 and gave the stock a “buy” rating in a research report on Monday, August 31st. Weiss Ratings upgraded HealthEquity from a “buy (b-)” rating to a “buy (b)” rating in a research note on Monday, November 2nd. BTIG Research reissued a “buy” rating and issued a $115.00 target price on shares of HealthEquity in a report on Friday, August 28th. Finally, Barclays boosted their target price on HealthEquity from $110.00 to $115.00 and gave the company an “overweight” rating in a report on Friday, September 18th. One investment analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $113.53.

HealthEquity Price Performance

Shares of HQY opened at $103.03 on Thursday. HealthEquity, Inc. has a twelve month low of $72.76 and a twelve month high of $110.26. The stock’s 50 day moving average is $95.90 and its two-hundred day moving average is $89.78. The firm has a market capitalization of $8.52 billion, a PE ratio of 37.20, a P/E/G ratio of 1.63 and a beta of 0.22. The company has a current ratio of 2.99, a quick ratio of 2.99 and a debt-to-equity ratio of 0.47.

HealthEquity (NASDAQ:HQY) last released its earnings results on Thursday, August 27th. The company reported $1.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.19 by $0.05. The company had revenue of $350.73 million for the quarter, compared to analysts’ expectations of $349.22 million. HealthEquity had a return on equity of 15.33% and a net margin of 17.36%. The business’s revenue was up 95.5% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. Research analysts anticipate that HealthEquity, Inc. will post 3.94 earnings per share for the current year.

Insider Buying and Selling at HealthEquity

In related news, Director Adrian Dillon sold 7,632 shares of HealthEquity stock in a transaction that occurred on Tuesday, August 25th. The stock was sold at an average price of $104.61, for a total value of $798,383.52. Following the sale, the director directly owned 62,395 shares in the company, valued at $6,527,140.95. The trade was a 10.90% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.60% of the stock is currently owned by company insiders.

HealthEquity Profile

HealthEquity, Inc. provides technology and services for health savings accounts (HSAs) and other consumer-directed benefits. Its platform supports employers, health plans, benefits advisers and individuals in managing health-related accounts and benefits. Alongside HSAs, the company administers flexible spending accounts, health reimbursement arrangements, commuter benefits and other workplace benefit programs. Its services include account administration, payment tools, customer support and investment options for eligible HSA funds.